increas
evid
point
host
inflammatori
respons
contribut
sever
lung
patholog
mortal
lower
respiratori
tract
infect
coronavirus
includ
host
inflammatori
cytokin
respons
caus
coronaviru
sar
studi
conduct
laboratori
anim
addit
concern
immun
enhanc
role
potenti
host
immunopatholog
result
experiment
human
vaccin
summar
evid
suggest
may
partial
overlap
underli
immunopatholog
process
link
coronaviru
infect
vaccin
role
immun
enhanc
eosinophil
pulmonari
immunopatholog
find
help
explain
link
viralvector
coronaviru
vaccin
immun
enhanc
reduct
alum
adjuv
addit
research
may
also
clarifi
link
pulmonari
immunopatholog
heart
diseas
increas
evid
point
host
inflammatori
respons
contribut
sever
lung
patholog
mortal
lower
respiratori
tract
infect
coronavirus
includ
host
inflammatori
cytokin
respons
caus
coronaviru
sar
studi
conduct
laboratori
anim
addit
concern
immun
enhanc
role
potenti
host
immunopatholog
result
experiment
human
vaccin
summar
evid
suggest
may
partial
overlap
underli
immunopatholog
process
link
coronaviru
infect
vaccin
role
immun
enhanc
eosinophil
pulmonari
immunopatholog
find
help
explain
link
viralvector
coronaviru
vaccin
immun
enhanc
reduct
alum
adjuv
addit
research
may
also
clarifi
link
pulmonari
immunopatholog
heart
diseas
caus
coronaviru
sar
emerg
third
major
lower
respiratori
tract
coronaviru
infect
st
centuri
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
hallmark
infect
viral
pneumonia
accompani
host
inflamm
lead
pulmonari
edema
syndrom
resembl
acut
respiratori
distress
syndrom
ard
new
inform
highlight
critic
role
host
inflammatori
respons
pathogenesi
pneumonia
edema
includ
releas
key
cytokin
includ
gmcsf
element
exacerb
viral
immnopathogenesi
downregul
treg
cell
promot
neutrophil
migrat
simultan
induc
respons
importantli
also
induc
pulmonari
eosinophil
respons
allerg
diseas
part
promot
eosinophil
product
bone
marrow
recruit
extravas
lung
cell
differenti
part
action
shown
import
role
lung
patholog
associ
sar
infect
addit
evid
suggest
sar
n
protein
potent
induc
respons
may
mediat
coronaviru
lung
patholog
although
confirmatori
studi
yet
perform
induc
presenc
coronavirus
lung
appear
promot
suscept
host
respons
may
lead
sever
lung
patholog
includ
eosinophilia
find
potenti
provid
ration
basi
evalu
monoclon
antibodi
new
therapi
addit
product
also
gener
condit
beyond
direct
virusinduc
patholog
immun
enhanc
associ
eosinophil
infiltr
immunopatholog
potenti
safeti
concern
link
firstgener
vaccin
prevent
sever
acut
respiratori
syndrom
sar
similar
phenomenon
may
derail
earli
effort
develop
inactiv
whole
viru
human
vaccin
respiratori
syncyti
viru
rsv
mechan
immun
enhanc
sar
vaccin
still
well
understood
case
postul
compon
antibodydepend
enhanc
ade
seen
sever
human
viral
infect
dengu
fever
other
differenti
eosinophil
immunopatholog
ade
key
element
eosinophil
immunopatholog
appear
inflammatori
infiltr
compris
mononuclear
cell
especi
eosinophil
histopatholog
section
lung
liver
vaccin
experiment
anim
follow
live
viru
challeng
promin
lung
eosinophil
led
investig
conclud
immun
enhanc
occur
immun
inde
unpublish
unreferenc
scientif
consensu
document
cepi
allianc
cepinet
argu
use
alum
adjuv
might
promot
respons
howev
publish
literatur
argu
primari
role
cell
directli
promot
immun
enhanc
exampl
alum
actual
diminish
immun
enhanc
laboratori
anim
vaccin
sar
coronaviru
use
either
inactiv
viru
viruslik
particl
vaccin
made
similar
observ
recombin
protein
receptor
bind
domain
vaccin
moreov
immun
enhanc
occur
primarili
follow
use
virusvector
vaccin
especi
use
vaccinia
construct
express
coronaviru
antigen
least
one
studi
mice
exhibit
immun
enhanc
follow
sar
viru
challeng
note
upregul
cytokin
downregul
antiinflammatori
cytokin
despit
exhibit
eosinophil
infiltr
although
anoth
studi
conclud
lack
adequ
induct
respons
asid
mix
respons
could
respons
also
explain
coronavirusvaccin
immun
enhanc
fig
vaccinia
vector
vaccin
induc
substanti
immun
enhanc
lung
liver
experiment
anim
case
link
viral
express
n
protein
none
studi
specif
examin
respons
howev
notabl
immun
enhanc
link
product
promin
cytokin
associ
well
mani
type
immun
respons
induct
promot
eosinophil
activ
infiltr
eosinophil
extravas
bone
marrow
lung
moreov
eosinophilia
shown
sustain
cell
despit
concern
notwithstand
fact
involv
sever
pulmonari
dysfunct
remain
unknown
contribut
cytokin
storm
enhanc
respons
pulmonari
eosinophilia
endstag
mortal
inde
evid
increasingli
suggest
sever
morbid
mortal
seen
may
far
heart
dysfunct
pulmonari
failur
sever
heart
failur
could
fact
main
caus
respiratori
organ
system
failur
sever
lifethreaten
diseas
respect
heart
failur
myocard
cardiomyopathi
also
link
produc
cell
cytokin
research
need
underli
mechan
eosinophil
immunopatholog
associ
coronaviru
vaccin
relev
observ
clinic
outcom
howev
potenti
role
respons
number
implic
term
product
clinic
develop
vaccin
includ
adjuv
select
vaccin
dose
rout
implic
also
also
inform
select
safest
vaccin
strategi
among
virusvector
nucleic
acidbas
platform
well
recombin
protein
subunit
vaccin
decis
valid
come
month
sever
vaccin
enter
clinic
pipelin
undergo
extens
evalu
efficaci
safeti
addit
possibl
eosinophildepend
immunopatholog
futur
vaccin
studi
might
focu
cardioprotect
effect
vaccin
